The new coronavirus, SARS-CoV-2, relies on a pH decrease to infect the target cell and replicate its RNA. This leads to a change in the electric potential of the cell’s membrane which in turn alters cell functions. Therapeutic intervention should therefore assist these cells in maintaining their natural electric membrane potential so that they can manage normal fluxes of heat and ions which are essential for survival. Results from our thermodynamic approach suggest to employ anti-SARS-CoV-2 therapeutic strategies that are capable to vary the Gibbs function, related to pH-dependent viral glycoproteins. Our approach lends theoretical credence to the potential benefit of using as starting points drugs such as chloroquine and hydroxychloroquine, while not minimizing their controversial risk profile as described recently in several COVID-19 clinical studies.

Seebeck-like effect in SARS-CoV-2 Bio-thermodynamics / Lucia, Umberto; Grisolia, Giulia; Deisboeck, Thomas S.. - In: ATTI DELLA ACCADEMIA PELORITANA DEI PERICOLANTI, CLASSE DI SCIENZE FISICHE, MATEMATICHE E NATURALI. - ISSN 1825-1242. - STAMPA. - 98:2A(2020), pp. 6-15. [10.1478/AAPP.982A6]

Seebeck-like effect in SARS-CoV-2 Bio-thermodynamics

Lucia, Umberto;Grisolia, Giulia;
2020

Abstract

The new coronavirus, SARS-CoV-2, relies on a pH decrease to infect the target cell and replicate its RNA. This leads to a change in the electric potential of the cell’s membrane which in turn alters cell functions. Therapeutic intervention should therefore assist these cells in maintaining their natural electric membrane potential so that they can manage normal fluxes of heat and ions which are essential for survival. Results from our thermodynamic approach suggest to employ anti-SARS-CoV-2 therapeutic strategies that are capable to vary the Gibbs function, related to pH-dependent viral glycoproteins. Our approach lends theoretical credence to the potential benefit of using as starting points drugs such as chloroquine and hydroxychloroquine, while not minimizing their controversial risk profile as described recently in several COVID-19 clinical studies.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11583/2854468